The company claims its Fertilo system can mature eggs outside the body using 80% fewer hormonal injections than typical ...

2025 年 1 月 13 日，庆应义塾大学医学院的研究人员在 Cell 子刊 Cell Reports Medicine 上发表了题为：A first-in-human clinical study of an allogenic iPSC-derived corneal ...

Gameto, a clinical-stage biotech company developing iPSC-based therapies for women’s health, today announced that the U.S.

application. US-based Gameto will now launch its multi-centre US trial to establish the efficacy of its ovarian support cell (OSC) technology designed to mature eggs outside the body using iPSC ...

World-renowned stem cell scientists will gather in Kyoto, Japan for the International Society for Stem Cell Research (ISSCR) ...

application for Fertilo, to enable the launch of the first US-based Phase 3 clinical trial for an induced pluripotent stem cell (iPSC)-based therapy. This groundbreaking milestone highlights the ...